Similar Search Results

The welfare impact of parallel imports : a structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - 2014

We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 anti-diabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...

Persistent link: https://www.econbiz.de/10010338113

The welfare impact of parallel imports : a structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - 2014

Persistent link: https://www.econbiz.de/10010339071

The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty

Ching, Andrew; Ishihara, Masakazu - 2010

Motivated by recent empirical findings on the relationship between new clinical evidence and the effectiveness of detailing, this paper develops a new structural model of detailing and prescribing decisions under the environment where both manufacturers and physicians are uncertain about drug...

Persistent link: https://www.econbiz.de/10014048404

Does TRIPS drive to productivity growth in Indian pharmaceutical industry : a non-parametric analysis

Jaswinder Singh; Parminder Singh - In: Paradigm : the journal of Institute of Management Technology 21 (2017) 2, pp. 211-228

Persistent link: https://www.econbiz.de/10012161057

The generics paradox revisited : empirical evidence from regulated markets

Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239

Persistent link: https://www.econbiz.de/10010345456

The welfare impact of parallel imports : a structural approach applied to the German market for oral anti-diabetics

Duso, Tomaso; Herr, Annika; Suppliet, Moritz - In: Health economics 23 (2014) 9, pp. 1036-1057

Persistent link: https://www.econbiz.de/10011306421

Pharmaceutical prices: the impact of the launch strategy : an analysis of German data

Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019

pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

Persistent link: https://www.econbiz.de/10012103333

Pharmaceutical prices : the impact of the launch strategy - an analysis of German data

Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019

Persistent link: https://www.econbiz.de/10012119750

R&D leverage : a measure to evaluate the impact of R&D on earnings of pharmaceutical companies

Bhagwat, Yatin; DeBruine, Marinus; Gondhalekar, Vijay - In: Journal of research in pharmaceutical economics 11 (2001) 3/4, pp. 55-68

Persistent link: https://www.econbiz.de/10001763344

Patents, price controls, and pharmaceuticals : considerations from political economy

Djolov, George G. - In: The journal of world intellectual property 6 (2003) 4, pp. 611-631

Persistent link: https://www.econbiz.de/10001872381